Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 18 No. 10, October 1997
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaller, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaller, J. G.
Related Collections
Right arrow Musculoskeletal Disorders

(Pediatrics in Review. 1997;18:337-349.)
© 1997 American Academy of Pediatrics

Juvenile Rheumatoid Arthritis

Jane G. Schaller, MD*

* David and Leona Karp Professor of Pediatrics; Chair, Department of Pediatrics, Tufts University School of Medicine, Boston, MA.


    IMPORTANT POINTS
 

  1. There are several recognizable subgroups of juvenile rheumatoid arthritis (JRA): systemic-onset, polyarticular, pauciarticular, and late childhood onset.
  2. Rheumatoid factor usually is negative in JRA.
  3. Systemic-onset JRA is characterized by high intermittent fevers and other extra-articular manifestations: lymphadenopathy, rash, pleuritis, and pericarditis.
  4. Iridocyclitis is absent in acute-onset disease but common in patients who have pauciarticular disease.
  5. Nonsteroidal anti-inflammatory drugs (NSAIDs) remain the front-line and important agents in the therapy of patients who have JRA.
  6. Controlled studies show that D-penicillamine, hydroxychloroquine, and oral gold are no more effective than placebo in the treatment of JRA.


    Introduction
 
Juvenile rheumatoid arthritis (JRA) is a term used to describe the condition of chronic synovitis in children of which there are several distinct subgroups. Chronic synovitis in children was first described well in the English literature in 1897 by George Frederick Still, an English pediatrician and pathologist, who reported on 23 children who had chronic arthritis and came to his attention while he was training at the Hospital for Sick Children, Great Ormond Street. Still postulated that several separate conditions were responsible for chronic arthritis in children. Little subsequent work in this area was pursued until the late 1940s. Most modern observers have come to agree with Still that chronic arthritis in children encompasses several distinct disease subgroups (Table 1Go ). The relationship of JRA to adult rheumatoid arthritis was uncertain for many years. Now it seems clear that the classic adult-type rheumatoid arthritis does occur in children but is quite rare, the JRA subgroups seronegative 1 polyarthritis and systemic-onset disease also occur in adults but not frequently, the pauciarthritis of early childhood has not been recognized in adults, and the pauciarthritis of older children usually is classified as spondyloarthropathy in adults. The nomenclature for chronic childhood arthritis remains confusing (Table 2Go ), but studies now underway . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
D. Glueck and H. Gellman
Management of the Upper Extremity in Juvenile Rheumatoid Arthritis
J. Am. Acad. Ortho. Surg., July 1, 2005; 13(4): 254 - 266.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
C. Kilcline, K. Shinkai, A. Bree, R. Modica, E. Von Scheven, and I. J. Frieden
Neonatal-Onset Multisystem Inflammatory Disorder: The Emerging Role of Pyrin Genes in Autoinflammatory Diseases
Arch Dermatol, February 1, 2005; 141(2): 248 - 253.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. J. Durbin and E. J. Mark
Case 18-2001- A 19-Month-Old Boy with Fever and Soft-Tissue Masses
N. Engl. J. Med., June 14, 2001; 344(24): 1851 - 1856.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1997 by the American Academy of Pediatrics.